DE69514217D1 - Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel - Google Patents

Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel

Info

Publication number
DE69514217D1
DE69514217D1 DE69514217T DE69514217T DE69514217D1 DE 69514217 D1 DE69514217 D1 DE 69514217D1 DE 69514217 T DE69514217 T DE 69514217T DE 69514217 T DE69514217 T DE 69514217T DE 69514217 D1 DE69514217 D1 DE 69514217D1
Authority
DE
Germany
Prior art keywords
pct
vaccine
containing composition
medicinal product
date sep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69514217T
Other languages
English (en)
Other versions
DE69514217T2 (de
Inventor
Vincent Ganne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Application granted granted Critical
Publication of DE69514217D1 publication Critical patent/DE69514217D1/de
Publication of DE69514217T2 publication Critical patent/DE69514217T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69514217T 1994-03-22 1995-03-21 Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel Expired - Lifetime DE69514217T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403361A FR2717694B1 (fr) 1994-03-22 1994-03-22 Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament.
PCT/FR1995/000345 WO1995025542A1 (fr) 1994-03-22 1995-03-21 Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et medicament

Publications (2)

Publication Number Publication Date
DE69514217D1 true DE69514217D1 (de) 2000-02-03
DE69514217T2 DE69514217T2 (de) 2000-09-07

Family

ID=9461309

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69514217T Expired - Lifetime DE69514217T2 (de) 1994-03-22 1995-03-21 Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel

Country Status (8)

Country Link
US (1) US5801157A (de)
EP (1) EP0751788B1 (de)
JP (1) JP3436371B2 (de)
AT (1) ATE188123T1 (de)
DE (1) DE69514217T2 (de)
ES (1) ES2144126T3 (de)
FR (1) FR2717694B1 (de)
WO (1) WO1995025542A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707896B1 (fr) * 1993-07-22 1995-09-01 Chemoxal Sa Procédé de traitement d'un article et nouvelle solution aqueuse de peroxyde d'hydrogène.
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2754715B1 (fr) * 1996-10-18 1998-11-13 Seppic Sa Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
DE19637043A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel und Reagenzien
US7097854B2 (en) 1996-09-12 2006-08-29 Medigene Oncology Gmbh Amino alcohol derivatives, process for their production and pharmaceutical preparations and reagents containing these compounds
FR2754182B1 (fr) * 1996-10-07 1998-11-06 Seppic Sa Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique
GB9626865D0 (en) * 1996-12-24 1997-02-12 Cyanamid Websters Pty Limited Veterinary vaccines
NZ503636A (en) * 1997-10-17 2002-05-31 Fort Dodge Australia Pty Vaccines for the prevention of clostridial diseases of sheep that provide effective immunity for up to a year or more from a single dose
FR2800280B1 (fr) 1999-10-29 2003-09-19 Seppic Sa Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
FR2814956B1 (fr) * 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
FR2922767B1 (fr) * 2007-10-24 2009-12-18 Seppic Sa Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649012B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
FR2700957B1 (fr) * 1993-01-29 1995-03-03 Seppic Sa Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.

Also Published As

Publication number Publication date
DE69514217T2 (de) 2000-09-07
WO1995025542A1 (fr) 1995-09-28
JPH09510359A (ja) 1997-10-21
ATE188123T1 (de) 2000-01-15
ES2144126T3 (es) 2000-06-01
US5801157A (en) 1998-09-01
EP0751788A1 (de) 1997-01-08
JP3436371B2 (ja) 2003-08-11
EP0751788B1 (de) 1999-12-29
FR2717694A1 (fr) 1995-09-29
FR2717694B1 (fr) 1996-05-03

Similar Documents

Publication Publication Date Title
BRPI9605663B8 (pt) Bis (resorcinil) triazinas.
DE69326776T2 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
BR9809691A (pt) Usos de substâncias de óleo
DE69627690D1 (de) Liposomale formulierungen von mitoxantron
DE69529748T2 (de) Polynukleotide vakzine gegen den papilloma virus
DE69514217D1 (de) Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel
ATE172636T1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
BR9709823B1 (pt) "compostos de amidas de ácido alqueno piridílico e alquino piridílico, métodos de preparação e uso dos mesmos, bem como medicamento".
HUP0001293A1 (hu) Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására
IL112111A0 (en) Peptide derivatives and pharmaceutical compositions containing them
BR9713884A (pt) Benzamida heterociclicamente substituìda, usos da mesma e de cetobenzamidoaldeìdos desta, e, preparação medicamentosa.
DK0823903T3 (da) Heterocykliske biarylforbindelser, farmaceutiske præparater og kosmetiske sammensætninger, der indeholder dem, og anvendelser
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
HK1079688A1 (en) Statin product for enhancing cognitive maintenance
DK0658553T3 (da) Hidtil ukendte polycykliske aromatiske forbindelser, farmaceutiske præparater og kosmetiske sammensætninger indeholdende di
HUT77029A (hu) A GAP-protein SH3 doménjéhez kötődni képes peptidek, ezeket kódoló nukleotidszekvenciák és előállításuk és alkalmazásuk
FR2763592B1 (fr) Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
KR970703428A (ko) Hcmv 및 hsv로부터의 융합 당단백질(fusion glycoprotein from hcmv and hsv)
DE69524581D1 (de) Retinal enthaltendes arzneimittel
ATE314481T1 (de) Promotor des transaldolase-genes von k.lactis und dessen verwendung
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
MY101874A (en) Vaccine
ATE245998T1 (de) Somatostatin agoniste zur reduzierung von körpergewicht

Legal Events

Date Code Title Description
8364 No opposition during term of opposition